부산대학교 도서관

Jacob, Stefan; Köhler, Martin; Tröster, Philip; Visa, Montse; García‐Prieto, Concha F.; Alanentalo, Tomas; Moede, Tilo; Leibiger, Barbara; Leibiger, Ingo B.; Berggren, Per‐Olof

The FASEB Journal

Kaßmann, M.; Szijártó, I. A.; García-Prieto, C. F.; Fan, G.; Schleifenbaum, J.; Anistan, Y.-M.; Tabeling, C.; Shi, Y.; Noble, F. le; Witzenrath, M.; Huang, Y.; Markó, L.; Nelson, M. T.; Gollasch, M.

J Am Heart Assoc
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 9 (2019)
Journal of the American Heart Association, 8 (9), e010090
Kaßmann, M, Szijártó, I A, García-Prieto, C F, Fan, G, Schleifenbaum, J, Anistan, Y M, Tabeling, C, Shi, Y, le Noble, F, Witzenrath, M, Huang, Y, Markó, L, Nelson, M T & Gollasch, M 2019, 'Role of Ryanodine Type 2 Receptors in Elementary Ca 2+ Signaling in Arteries and Vascular Adaptive Responses', Journal of the American Heart Association, vol. 8, no. 9, pp. e010090. https://doi.org/10.1161/JAHA.118.010090

Santos-Pujol E; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Noguera-Castells A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Casado-Pelaez M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.; Vasallo C; BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; Institute of Evolutionary Biology (IBE, UPF-CSIC), Department of Medicine and Life, Barcelona, Catalonia, Spain.; Campillo-Marcos I; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Quero-Dotor C; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Crespo-García E; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Bueno-Costa A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Setién F; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Ferrer G; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Davalos V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Mereu E; Cellular Systems Genomics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Pluvinet R; Genomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; High Content Genomics and Bioinformatics (HCGB)-Germans Trias I Pujol Research Institute (IGTP), Badalona, Barcelona, Catalonia, Spain.; Arribas C; Genomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Torre C; Proteomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Villavicencio F; Department of Economic, Financial and Actuarial Mathematics, University of Barcelona, Barcelona, Catalonia, Spain.; Sumoy L; High Content Genomics and Bioinformatics (HCGB)-Germans Trias I Pujol Research Institute (IGTP), Badalona, Barcelona, Catalonia, Spain.; Granada I; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Coles NS; Los Angeles Gerontology Research Group, Los Angeles, CA, USA.; Acha P; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Solé F; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Mallo M; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Microarrays Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Mata C; Single Cell Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Peregrina S; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.; Gabaldón T; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA) and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Llirós M; Bioinformatics and Bioimaging (BI-SQUARED) Research Group, Biosciences Department, Faculty of Science, Technology and Engineering, Universitat de Vic - Universitat Central de Catalunya, Vic, Catalunya, Spain.; Pujolassos M; Bioinformatics and Bioimaging (BI-SQUARED) Research Group, Biosciences Department, Faculty of Science, Technology and Engineering, Universitat de Vic - Universitat Central de Catalunya, Vic, Catalunya, Spain.; Carreras-Torres R; Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain.; Lluansí A; Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain; Infectious diseases and Microbiome Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Catalunya, Spain.; García-Gil LJ; Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain; Biology Department, Universitat de Girona, Girona, Catalunya, Spain.; Aldeguer X; Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain; Digestive Service, Hospital Universitari de Girona Dr Josep Trueta, Girona, Catalunya, Spain.; Samino S; Biosfer Teslab, 43201 Reus, Tarragona, Spain.; Torné P; Biosfer Teslab, 43201 Reus, Tarragona, Spain.; Ribalta J; Universitat Rovira i Virgili, Department of Basic Medical Sciences, Reus, Spain; Institut d'Investigació Sanitària Pere Virgili, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Guardiola M; Universitat Rovira i Virgili, Department of Basic Medical Sciences, Reus, Spain; Institut d'Investigació Sanitària Pere Virgili, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Amigó N; Biosfer Teslab, 43201 Reus, Tarragona, Spain; Universitat Rovira i Virgili, Department of Basic Medical Sciences, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Yanes O; Institut d'Investigació Sanitària Pere Virgili, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Universitat Rovira i Virgili, Department of Electronic Engineering, Tarragona, Spain.; Martínez P; Telomeres and Telomerase Group - Fundación Humanismo y Ciencia, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Sánchez-Vázquez R; Telomeres and Telomerase Group - Fundación Humanismo y Ciencia, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Blasco MA; Telomeres and Telomerase Group - Fundación Humanismo y Ciencia, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Oviedo J; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ, USA.; Lemos B; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ, USA; Coit Center for Longevity and Neurotherapeutics, The University of Arizona, Tucson, AZ, USA.; Rius-Bonet J; BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain.; Torrubiano M; epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain.; Massip-Salcedo M; BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain.; Khidir KA; Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK; University of Raparin, Kurdistan Region, Iraq.; Cao TH; Department of Cardiovascular Sciences, College of Life Sciences, University of Leicester, Leicester LE1 7RH, UK; National Institute for Health and Care Research Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester LE3 9QP, UK; Leicester van Geest MultiOMICS Facility, University of Leicester, Leicester LE1 7RH, UK.; Quinn PA; Department of Cardiovascular Sciences, College of Life Sciences, University of Leicester, Leicester LE1 7RH, UK; Leicester van Geest MultiOMICS Facility, University of Leicester, Leicester LE1 7RH, UK.; Jones DJL; Leicester van Geest MultiOMICS Facility, University of Leicester, Leicester LE1 7RH, UK; Leicester Cancer Research Centre, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, University of Leicester, Leicester LE1 5WW, UK.; Macip S; BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain; Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK.; Brigos-Barril E; Institute of Evolutionary Biology (IBE, UPF-CSIC), Department of Medicine and Life, Barcelona, Catalonia, Spain; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.; Moldes M; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.; Barteri F; BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain.; Muntané G; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain; Hospital Universitari Institut Pere Mata (HUIPM), Institut d'Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili (URV), Catalonia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Laayouni H; BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.; Navarro A; BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; Institute of Evolutionary Biology (IBE, UPF-CSIC), Department of Medicine and Life, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA) and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.; Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA) and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain. Electronic address: mesteller@carrerasresearch.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Martinez-Verbo, L; Villanueva, L; Llinàs-Arias, P; García-Prieto, CA; Piñeyro, D; Oliver-Caldes, A; García-Ortiz, A; Valeri, A; de Larrea, CF; Martinez-Lopez, J; Ferrer, G; Esteller, M

Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Thomas N; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.; García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.; Dreval K; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.; Hilton LK; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.; Centre for Lymphoid Cancer, BC Cancer, Vancouver, Canada.; Abramson JS; Center for Lymphoma, Massachusetts General Hospital, Boston, Massachusetts.; Bartlett NL; Washington University School of Medicine, St. Louis, Missouri.; Bethony J; George Washington University, Washington, District of Columbia.; Bowen J; Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio.; Bryan AC; Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio.; Casper C; Access to Advanced Health Institute, Seattle, Washington.; Dyer MA; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Gastier-Foster JM; Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio.; Department of Pathology and Laboratory Medicine, Ohio State University, Columbus, Ohio.; Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.; Gerrie AS; Centre for Lymphoid Cancer, BC Cancer, Vancouver, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, British Columbia.; Greiner TC; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska.; Griner NB; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland.; Gross TG; Center for Global Health, National Cancer Institute, NIH, Rockville, Maryland.; Harris N; Department of Pathology, Massachusetts General Hospital, Boston, Maryland.; Irvin JD; Foundation for Burkitt Lymphoma Research, Geneva, Switzerland.; Jaffe ES; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Leal FE; Programa de Oncovirologia, Instituto Nacional de Cancer, Rio de Janeiro, Brazil.; Mbulaiteye SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Silver Spring, Maryland.; Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.; Mungall KL; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.; Namirembe C; Uganda Cancer Institute, Kampala, Uganda.; Noy A; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical School, New York, New York.; Ogwang MD; St. Mary's Hospital, Gulu, Uganda.; Orem J; Uganda Cancer Institute, Kampala, Uganda.; Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; Petrello H; Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio.; Reynolds SJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.; Swerdlow SH; Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Traverse-Glehen A; Service d'Anatomie pathologique, Université Lyon 1/Centre Hospitalier Lyon Sud, Pierre Bénite, France.; Wilson WH; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.; Centre for Lymphoid Cancer, BC Cancer, Vancouver, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia.; Staudt LM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, British Columbia.; Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.; Morin RD; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.; Centre for Lymphoid Cancer, BC Cancer, Vancouver, Canada.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Noguera-Castells A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Campillo-Marcos I; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Davalos V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.; Valcárcel D; Department of Hematology, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain.; Molero A; Department of Hematology, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain.; Palomo L; Department of Hematology, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain.; Gattermann N; Department of Hematology, Oncology and Clinical Immunology, University Cancer Center, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.; Wulfert M; Department of Hematology, Oncology and Clinical Immunology, University Cancer Center, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.; Chaparro-González L; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Solé F; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Cabezón M; Department of Hematology, ICO-IJC-Hospital Germans Trias i Pujol, UAB, Badalona, Catalonia, Spain.; Myeloid neoplasms Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Jiménez-Lorenzo MJ; Department of Hematology, ICO-IJC-Hospital Germans Trias i Pujol, UAB, Badalona, Catalonia, Spain.; Myeloid neoplasms Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Xicoy B; Department of Hematology, ICO-IJC-Hospital Germans Trias i Pujol, UAB, Badalona, Catalonia, Spain.; Myeloid neoplasms Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Zamora L; Department of Hematology, ICO-IJC-Hospital Germans Trias i Pujol, UAB, Badalona, Catalonia, Spain.; Myeloid neoplasms Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; De Stefano A; Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.; Casalin I; Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.; Finelli C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology 'Seràgnoli', Bologna, Italy.; Follo MY; Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.; Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Noguera-Castells A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Spain.; García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.; Álvarez-Errico D; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101265293 Publication Model: Print Cited Medium: Internet ISSN: 1559-2308 (Electronic) Linking ISSN: 15592294 NLM ISO Abbreviation: Epigenetics Subsets: MEDLINE

Noguera-Castells A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029, Madrid, Spain.; Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain.; García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.; Ferrer G; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029, Madrid, Spain.; Davalos V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029, Madrid, Spain.; Setien F; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Genescà E; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Ribera J; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Ribera JM; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Department of Hematology, Catalan Institute of Oncology (ICO), Hospital Germans Trias i Pujol, Badalona, Barcelona, Catalonia, Spain.; School of Medicine, Universitat Autònoma de Barcelona, Badalona, Barcelona, Catalonia, Spain.; Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029, Madrid, Spain. mesteller@carrerasresearch.org.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process

Ortiz-Barahona V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Soler M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Davalos V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.; Janin M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Setien F; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Fernández-Rebollo I; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Bech-Serra JJ; Proteomics Unit, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; De La Torre C; Proteomics Unit, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Guil S; Regulatory RNA and Chromatin Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Germans Trias i Pujol Health Science Research Institute, Barcelona, Catalonia, Spain.; Villanueva A; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Zhang PH; Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.; Center for Molecular Medicine, Children's Hospital, Fudan University and Shanghai Key Laboratory of Medical Epigenetics, International Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.; Yang L; Center for Molecular Medicine, Children's Hospital, Fudan University and Shanghai Key Laboratory of Medical Epigenetics, International Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.; Guarnacci M; Shine-Dalgarno Centre for RNA Innovation, Australian National University, Canberra, Australia.; Schumann U; Shine-Dalgarno Centre for RNA Innovation, Australian National University, Canberra, Australia.; Preiss T; Shine-Dalgarno Centre for RNA Innovation, Australian National University, Canberra, Australia.; Victor Chang Cardiac Research Institute, Darlinghurst (Sydney), Queensland, NSW, 2010, Australia.; Balaseviciute U; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, Spain.; Montal R; Hospital Arnau de Vilanova, IRBLleida, University of Lleida (UdL), Catalonia, Spain.; Llovet JM; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, Spain.; ICAHN School of Medicine at Mount Sinai, New York, NY, USA.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, 08010, Spain.; Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain. mesteller@carrerasresearch.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, 08010, Spain. mesteller@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer, Madrid, 28029, Spain. mesteller@carrerasresearch.org.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, 08907, Spain. mesteller@carrerasresearch.org.

Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

González-Sampériz, P. ; Gil-Romera, G. ; García-Prieto, E. ; Aranbarri, J. ; Moreno, A. ; Morellón, M. ; Sevilla-Callejo, M. ; Leunda, M. ; Santos, L. ; Franco-Múgica, F. ; Andrade, A. ; Carrión, J.S. ; Valero-Garcés, B.L.

In Quaternary Science Reviews 15 August 2020 242

Martinez-Verbo L; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.; Veselinova Y; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.; Llinàs-Arias P; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.; García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.; Barcelona Supercomputing Center (BSC), Barcelona, Spain.; Noguera-Castells A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.; Pato ML; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.; Bueno-Costa A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.; Campillo-Marcos I; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Villanueva L; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.; Oliver-Caldes A; Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Cardus O; Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Salsench SV; Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; García-Ortiz A; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Hospital Universitario 12 de Octubre-Centro Nacional de Investigaciones Oncológicas (H12O-CNIO). Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain.; Valeri A; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Hospital Universitario 12 de Octubre-Centro Nacional de Investigaciones Oncológicas (H12O-CNIO). Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain.; Rojas EA; Department of Hematology, University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Barrena N; Universidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, Spain.; Gutiérrez NC; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Hematology, University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Prósper F; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Servicio de Hematología y Terapia Celular, Clínica Universidad de Navarra (CUN), Pamplona, Spain.; Agirre X; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Fernández de Larrea C; Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Martínez-López J; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Hospital Universitario 12 de Octubre-Centro Nacional de Investigaciones Oncológicas (H12O-CNIO). Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain.; Ferrer G; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain. gferrer@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain. gferrer@carrerasresearch.org.; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, USA. gferrer@carrerasresearch.org.; Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain. mesteller@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain. mesteller@carrerasresearch.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. mesteller@carrerasresearch.org.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain. mesteller@carrerasresearch.org.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process

Malla S; Department of Molecular Biology, Umeå University, Umeå, Sweden.; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.; Kumari K; Department of Molecular Biology, Umeå University, Umeå, Sweden.; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.; García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.; Caroli J; Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.; Nordin A; Wallenberg Centre for Molecular Medicine, Linköping University, Linköping, Sweden.; Department of Biomedical and Clinical Sciences, Division of Molecular Medicine and Virology, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.; Phan TTT; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Bhattarai DP; Department of Molecular Biology, Umeå University, Umeå, Sweden.; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.; Martinez-Gamero C; Department of Molecular Biology, Umeå University, Umeå, Sweden.; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.; Dorafshan E; Department of Molecular Biology, Umeå University, Umeå, Sweden.; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.; Stransky S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, USA.; Álvarez-Errico D; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Saiki PA; Department of Molecular Biology, Umeå University, Umeå, Sweden.; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.; Lai W; State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.; Lyu C; State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.; Lizana L; Department of Physics, Integrated Science Lab, Umeå University, Umeå, Sweden.; Gilthorpe JD; Department of Medical and Translational Biology, Umeå University, Umeå, Sweden.; Wang H; State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.; Sidoli S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, USA.; Mateus A; Department of Chemistry, Umeå University, Umeå, Sweden.; The Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå, Sweden.; Lee DF; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.; Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Cantù C; Wallenberg Centre for Molecular Medicine, Linköping University, Linköping, Sweden.; Department of Biomedical and Clinical Sciences, Division of Molecular Medicine and Virology, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.; Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.; Mattevi A; Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.; Roman AC; Department of Biochemistry, Molecular Biology and Genetics, University of Extremadura, Badajoz, Spain.; Aguilo F; Department of Molecular Biology, Umeå University, Umeå, Sweden. francesca.aguilo@umu.se.; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden. francesca.aguilo@umu.se.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Aranbarri, Josu ; González-Sampériz, Penélope ; Iriarte, Eneko ; Moreno, Ana ; Rojo-Guerra, Manuel ; Peña-Chocarro, Leonor ; Valero-Garcés, Blas ; Leunda, Maria ; García-Prieto, Eduardo ; Sevilla-Callejo, Miguel ; Gil-Romera, Graciela ; Magri, Donatella ; Rodríguez-Lázaro, Julio

In Palaeogeography, Palaeoclimatology, Palaeoecology 15 October 2015 436:41-57

Corbacho I; Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias, Universidad de Extremadura, Avda. de Elvas s/n, 06006 Badajoz, Spain.; García-Prieto FF; Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias, Universidad de Extremadura, Avda. de Elvas s/n, 06006 Badajoz, Spain.; Hinojosa AE; Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias, Universidad de Extremadura, Avda. de Elvas s/n, 06006 Badajoz, Spain.; Berrocal M; Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias, Universidad de Extremadura, Avda. de Elvas s/n, 06006 Badajoz, Spain.; Mata AM; Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias, Universidad de Extremadura, Avda. de Elvas s/n, 06006 Badajoz, Spain. Electronic address: anam@unex.es.

Publisher: Academic Press Country of Publication: United States NLM ID: 9101496 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0279 (Electronic) Linking ISSN: 10465928 NLM ISO Abbreviation: Protein Expr Purif Subsets: MEDLINE

Noguera-Castells A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Parra J; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain.; Davalos V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain.; García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.; Veselinova Y; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain.; Pérez-Miés B; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Department of Medicine and Medical Specialties, University of Alcalá, Alcalá de Henares (Madrid), Spain.; Caniego-Casas T; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Palacios J; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Department of Medicine and Medical Specialties, University of Alcalá, Alcalá de Henares (Madrid), Spain.; Saenz-Sardà X; Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Englund E; Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Musulen E; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Department of Pathology, Hospital Universitari General de Catalunya Grupo-QuirónSalud, Barcelona, Catalonia, Spain.; Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain. Electronic address: mesteller@carrerasresearch.org.

Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: MEDLINE

Aranbarri, Josu ; González-Sampériz, Penélope ; Valero-Garcés, Blas ; Moreno, Ana ; Gil-Romera, Graciela ; Sevilla-Callejo, Miguel ; García-Prieto, Eduardo ; Di Rita, Federico ; Mata, M. Pilar ; Morellón, Mario ; Magri, Donatella ; Rodríguez-Lázaro, Julio ; Carrión, José S.

In Global and Planetary Change March 2014 114:50-65

María Clara Chavarín-García Prieto; Carmen Lizette Gálvez-Hernández

Psicología Iberoamericana. 26:11-21

Joshi RS; Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916 Barcelona, Spain.; Rigau M; Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.; García-Prieto CA; Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916 Barcelona, Spain; Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.; Castro de Moura M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916 Barcelona, Spain.; Piñeyro D; Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916 Barcelona, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029 Madrid, Spain.; Moran S; Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916 Barcelona, Spain.; Davalos V; Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916 Barcelona, Spain.; Carrión P; Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), 08003 Barcelona, Spain.; Ferrando-Bernal M; Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), 08003 Barcelona, Spain.; Olalde I; Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), 08003 Barcelona, Spain.; Lalueza-Fox C; Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), 08003 Barcelona, Spain.; Navarro A; Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), 08003 Barcelona, Spain; Centre for Genomic Regulation (CNAG-CRG), 08003 Barcelona, Catalonia, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.; Fernández-Tena C; Herta Security, S.L., 08037 Barcelona, Spain.; Aspandi D; Departament de Tecnologies de la Informació i les Comunicaciones (DTIC), Universitat Pompeu Fabra (UPF), 08018 Barcelona, Spain.; Sukno FM; Departament de Tecnologies de la Informació i les Comunicaciones (DTIC), Universitat Pompeu Fabra (UPF), 08018 Barcelona, Spain.; Binefa X; Departament de Tecnologies de la Informació i les Comunicaciones (DTIC), Universitat Pompeu Fabra (UPF), 08018 Barcelona, Spain.; Valencia A; Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.; Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916 Barcelona, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029 Madrid, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), L'Hospitalet, 08907 Barcelona, Spain. Electronic address: mesteller@carrerasresearch.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Bueno-Costa A; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Piñeyro D; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029, Madrid, Spain.; García-Prieto CA; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.; Ortiz-Barahona V; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Martinez-Verbo L; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Webster NA; STORM Therapeutics Ltd, Cambridge, UK.; Andrews B; STORM Therapeutics Ltd, Cambridge, UK.; Kol N; Cancer Research Center and Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Avrahami C; Cancer Research Center and Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Moshitch-Moshkovitz S; Cancer Research Center and Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Rechavi G; Cancer Research Center and Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029, Madrid, Spain. mesteller@carrerasresearch.org.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Davalos V; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; García-Prieto CA; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.; Ferrer G; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Spain.; Aguilera-Albesa S; Navarra Health Service Hospital, Pamplona, Spain.; Valencia-Ramos J; University Hospital of Burgos, Burgos, Spain.; Rodríguez-Palmero A; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.; Germans Trias i Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona (UAB), Badalona, Barcelona, Spain.; Ruiz M; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.; Planas-Serra L; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.; Jordan I; Pediatric Critical Care Unit, Hospital Universitari Sant Joan de Deu, Barcelona, Catalonia, Spain.; Alegría I; Navarra Health Service Hospital, Pamplona, Spain.; Flores-Pérez P; Pediatrics Department, Hospital Universitario Niño Jesús, Madrid, Spain.; Cantarín V; Pediatrics Department, Hospital Universitario Niño Jesús, Madrid, Spain.; Fumadó V; Unitat de Malalties Infeccioses i Importades, Servei de Pediatría, Infectious and Imported Diseases, Pediatric Unit, Hospital Universitari Sant Joan de Deú, Barcelona, Catalonia, Spain.; Viadero MT; Servicio de Pediatría del Hospital Universitario Marqués de Valdecilla, Santander, Spain.; Rodrigo C; Germans Trias i Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona (UAB), Badalona, Barcelona, Spain.; Méndez-Hernández M; Germans Trias i Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona (UAB), Badalona, Barcelona, Spain.; López-Granados E; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.; Department of Immunology, La Paz University Hospital, Madrid, Spain; La Paz Institute of Biomedical Research, Madrid, Spain.; Colobran R; Immunology Division, Department of Clinical and Molecular Genetics, Hospital Universitari Vall d'Hebron (HUVH), Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.; Rivière JG; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron (HUVH), Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.; Soler-Palacín P; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron (HUVH), Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.; Pujol A; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.; Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Catalonia, Spain.

Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE